14 37.84 37.13 36.95 36.10 35.77 22.274 6a 40.92 38.89 38.22 36.05 35.61 33.65 32.94 32.17 31.57 30.46 52.953 6b 49.15 47.06 45.27 43.36 42.66 41.98 FRAX597 39.12 38.44 37.26 36.29 1.119 6c 38.98 38.32 36.52 35.08
34.91 34.79 34.15 33.59 32.75 30.41 12.829 6d 49.15 47.26 45.31 43.41 41.96 41.18 39.12 37.05 36.38 35.51 1.816 6e 54.52 51.14 50.83 49.22 48.64 47.65 45.39 42.38 41.25 38.76 1.018 6f 65.97 59.62 57.09 55.18 54.64 51.26 48.28 46.54 44.85 41.28 0.978 6g 46.01 43.19 42.63 41.32 40.65 39.82 37.34 36.75 34.95 33.52 3.108 7a 36.94 36.21 35.13 34.55 32.17 30.41 29.35 29.17 28.36 27.44 10.735 7b 42.44 41.12 40.65 39.07 38.79 37.41 37.05 35.48 33.62 33.48 13.829 7c 40.27 38.88 38.60 38.21 38.04 37.79 36.59 34.75 34.03 33.23 1.164 7d 38.92 38.50 37.91 35.98 35.37 35.66 35.17 34.59 34.13 33.72 6.342 7e 36.05 35.80 35.53 34.87 34.52 33.48 31.75 30.46 29.97 29.04 12.729 7f 67.99 65.83 60.68 56.43 52.12 46.10 42.62 40.07 39.26 38.76 1.784
Anlotinib molecular weight 7g 38.99 38.74 37.12 36.26 36.11 35.72 35.32 33.62 32.79 30.66 10.215 9a 42.36 41.13 39.07 38.10 37.89 37.01 36.15 35.32 34.84 33.29 5.674 9b 37.99 37.72 37.02 36.62 36.47 36.11 35.72 35.43 29.46 27.75 1.487 9c 43.51 40.34 38.19 37.73 36.15 35.87 35.12 34.15 33.25 31.49 5.726 9d 53.02 48.22 47.78 43.14 41.21 40.59 38.31 37.46 36.27 35.65 2.268 9e 51.36 49.32 48.22 47.61 45.79 43.35 42.54 41.86 40.27 39.11 12.763 9f 40.39 38.72 37.14 36.91 35.67 34.95 33.42 32.39 31.24 30.26 17.327 9g 42.47 39.75 39.20 38.61 37.51 36.33 35.06 34.11 33.17 32.72 166.376 9h 39.98 39.25 37.94 37.46 37.24 36.39 36.32
35.35 35.01 32.85 1.467 9i 38.66 38.57 36.72 35.27 34.95 34.59 34.14 33.97 33.92 33.61 9.215 9j 52.43 45.35 42.72 39.13 37.04 36.06 35.27 34.62 33.23 32.98 0.913 ISL 59.26 44.69 38.58 36.46 34.12 32.98 31.11 30.20 28.42 26.37 0.313 aCTC50 cytotoxicity concentration (μM) determined experimentally The order of cytotoxic activity was electron-withdrawing group on phenyl > electron-donating group on phenyl > phenyl. Conclusion Thiadiazoles are mesoionic system, a poly-heteroatomic Dehydrogenase inhibitor system containing a five-membered heterocycle associated with a conjugation of p and π electrons and distinct regions of positive next and negative charges leading to highly polarizable derivatives.